SynthesisRMD open2021
Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilar.
Juliette Petit et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it